The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat

被引:35
作者
Ohge, H
Furne, JK
Springfield, J
Sueda, T
Madoff, RD
Levitt, MD
机构
[1] Vet Adm Med Ctr, Res Serv, Minneapolis, MN 55417 USA
[2] Hiroshima Univ, Dept Surg, Div Clin Med Sci, Minami Ku, Hiroshima 7348551, Japan
[3] Univ Minnesota, Dept Surg, Div Colon & Rectal Surg, St Paul, MN 55104 USA
关键词
hydrogen sulfide; sulfate-reducing bacteria; ciprofloxacin; bismuth;
D O I
10.1016/S0378-1097(03)00748-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Colonic bacteria produce the highly toxic thiol, hydrogen sulfide. Despite speculation that this compound induces colonic mucosal injury, there is little information concerning manipulations that might reduce its production. We studied the effect of antibiotics and bismuth on the production of hydrogen sulfide in rats. Baseline fecal samples were analyzed for hydrogen sulfide concentration and release rate during incubation and numbers of sulfate-reducing bacteria. Groups of six rats received daily doses of ciprofloxacin, metronidazole. or sulfasalazine for one week, and feces were reanalyzed. Bismuth subnitrate was then added to the antibiotic regimens. While sulfide production and sulfate-reducing bacteria were resistant to treatment with ciprofloxacin or metronidazole, bismuth acted synergistically with ciprofloxacin to inhibit sulfate-reducing bacteria growth and to reduce sulfide production. Combination antibiotic-bismuth therapy could provide insights into the importance of sulfide and sulfate-reducing bacteria in both human and animal models of colitis and have clinical utility in the treatment of anti biotic-resistant enteric pathogens. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 22 条
[1]   A CRITICAL-REVIEW OF THE LITERATURE ON HYDROGEN-SULFIDE TOXICITY [J].
BEAUCHAMP, RO ;
BUS, JS ;
POPP, JA ;
BOREIKO, CJ ;
ANDJELKOVICH, DA .
CRC CRITICAL REVIEWS IN TOXICOLOGY, 1984, 13 (01) :25-97
[2]   BUTYRATE OXIDATION IS IMPAIRED IN THE COLONIC MUCOSA OF SUFFERERS OF QUIESCENT ULCERATIVE-COLITIS [J].
CHAPMAN, MAS ;
GRAHN, MF ;
BOYLE, MA ;
HUTTON, M ;
ROGERS, J ;
WILLIAMS, NS .
GUT, 1994, 35 (01) :73-76
[3]   The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria [J].
Edmond, LM ;
Hopkins, MJ ;
Magee, EA ;
Cummings, JH .
INFLAMMATORY BOWEL DISEASES, 2003, 9 (01) :10-17
[4]  
FLORIN T H J, 1990, Gastroenterology, V98, pA170
[5]  
GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x
[6]  
GLUPCZYNSKI Y, 1988, AM J GASTROENTEROL, V83, P365
[7]   BISMUTH THERAPY IN GASTROINTESTINAL-DISEASES [J].
GORBACH, SL .
GASTROENTEROLOGY, 1990, 99 (03) :863-875
[8]  
GORBACH SL, 1990, REV INFECT DIS, V12, pS21
[9]   EVALUATION OF THE SEMISOLID POSTGATES-B MEDIUM FOR ENUMERATING SULFATE-REDUCING BACTERIA [J].
JAIN, DK .
JOURNAL OF MICROBIOLOGICAL METHODS, 1995, 22 (01) :27-38
[10]   Fecal hydrogen sulfide production in ulcerative colitis [J].
Levine, J ;
Ellis, CJ ;
Furne, JK ;
Springfield, J ;
Levitt, MD .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (01) :83-87